Related Experiment Video
Updated: Jan 23, 2026

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
Published on: July 16, 2021
FGF21 Mediates Mesenchymal Stem Cell Senescence via Regulation of Mitochondrial Dynamics
Xin Li1, Yimei Hong1,2, Haiwei He1,2
1Department of Emergency Medicine, Department of Emergency and Critical Care Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China.
Abstract:
Mesenchymal stem cell- (MSC-) based therapy is a novel strategy in regenerative medicine. The functional and regenerative capacities of MSCs decline with senescence. Nonetheless, the potential mechanisms that underlie their senescence are not fully understood. This study was aimed at exploring the potential mechanisms of fibroblast growth factor 21 (FGF21) in the regulation of MSC senescence. The senescence of MSCs was determined by senescence-associated β-galactosidase (SA-β-gal) staining. The morphology and the level of mitochondrial reactive oxygen species (ROS) of MSCs were assessed by MitoTracker and Mito-Sox staining, respectively. The expression of FGF21 and mitochondrial dynamics-related proteins was detected by Western blotting. As MSCs were expanded in vitro, the expression of FGF21 decreased. Depletion of FGF21 enhanced production of mitochondrial reactive oxidative species (ROS) and increased the senescence of early-passage MSCs whereas inhibition of ROS abolished these effects. The senescent MSCs exhibited increased mitochondrial fusion and decreased mitochondrial fission. Treatment of early-passage MSCs with FGF21 siRNA enhanced mitochondrial fusion and reduced mitochondrial fission. Moreover, treatment of mitofusin2- (Mfn2-) siRNA inhibited depletion of FGF21-induced MSC senescence. Furthermore, we demonstrated that depletion of FGF21-induced mitochondrial fusion was regulated by the AMPK signaling pathway. Treatment with an AMPK activator, AICAR, abrogated the depletion of FGF21-induced senescence of MSCs by inhibiting mitochondrial fusion. Compared with MSCs isolated from young donors, those derived from aged donors showed a lower level of FGF21 and a higher level of senescent activity. Furthermore, overexpression of FGF21 in aged MSCs inhibited senescence. Our study shows that FGF21, via the AMPK signaling pathway, regulates the senescence of MSCs by mediating mitochondrial dynamics. Targeting FGF21 might represent a novel strategy to improve the quality and quantity of MSCs.
Insights
Fibroblast growth factor 21 (FGF21) regulates mesenchymal stem cell (MSC) senescence by controlling mitochondrial dynamics through the AMPK pathway. Targeting FGF21 may enhance MSC quality for regenerative medicine.
Area of Science:
- Regenerative Medicine
- Cellular Senescence
- Mitochondrial Dynamics
Background:
- Mesenchymal stem cells (MSCs) are crucial for regenerative medicine, but their therapeutic potential declines with senescence.
- The underlying mechanisms of MSC senescence remain incompletely understood.
- Fibroblast growth factor 21 (FGF21) is investigated for its role in regulating MSC senescence.
Purpose of the Study:
- To explore the mechanisms by which FGF21 regulates MSC senescence.
- To investigate the link between FGF21, mitochondrial dynamics, and MSC aging.
Main Methods:
- Senescence-associated β-galactosidase (SA-β-gal) staining to assess MSC senescence.
- MitoTracker and Mito-Sox staining for mitochondrial morphology and reactive oxygen species (ROS).
- Western blotting for FGF21 and mitochondrial dynamics proteins; siRNA and AMPK activator (AICAR) treatments.
Main Results:
- In vitro MSC expansion led to decreased FGF21 expression, increased ROS, and enhanced senescence.
- FGF21 depletion promoted mitochondrial fusion and reduced fission, mediated by the AMPK pathway.
- Aged MSCs showed lower FGF21 and higher senescence; FGF21 overexpression inhibited senescence in aged MSCs.
Conclusions:
- FGF21 regulates MSC senescence by modulating mitochondrial dynamics via the AMPK signaling pathway.
- FGF21 depletion induces senescence through increased mitochondrial fusion and ROS production.
- Targeting FGF21 presents a potential strategy to improve MSC quality and quantity for therapeutic applications.
More Related Videos
06:50Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells
Replicative Cell Senescence
Animal Mitochondrial Genetics
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...